Hinova Pharmaceuticals Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	633.44	813.23	1,202	901.22
Trading Asset Securities	-	210.49	290.62	366.24	-
Cash & Short-Term Investments	917.05	843.93	1,104	1,568	901.22
Cash Growth	8.66%	-23.55%	-29.59%	73.97%	-20.85%
Other Receivables	-	0.84	1.39	1.67	0.54
Receivables	-	0.84	1.39	1.67	0.54
Inventory	-	0	0.01	0.01	0
Prepaid Expenses	-	-	-	-	13.09
Other Current Assets	-	40.77	41.99	41.78	40.38
Total Current Assets	-	885.54	1,147	1,611	955.24
Property, Plant & Equipment	-	328.62	187.99	86.61	12.72
Long-Term Investments	-	113.09	109.98	5	-
Other Intangible Assets	-	30.56	31.21	31.86	-
Long-Term Deferred Charges	-	-	0.04	0.08	-
Other Long-Term Assets	-	3.77	15.12	0.21	14.39
Total Assets	-	1,362	1,492	1,735	982.35
Accounts Payable	-	40.63	3.14	2.29	1.31
Accrued Expenses	-	31.09	49.17	69.81	90.45
Short-Term Debt	-	-	-	30	-
Current Portion of Leases	-	3.22	3.77	2.45	2.8
Other Current Liabilities	-	72.01	50.76	33.73	96.77
Total Current Liabilities	-	146.95	106.84	138.27	191.33
Long-Term Leases	-	5.83	9.08	3.31	1.11
Long-Term Unearned Revenue	-	16.55	8.55	8.1	1.15
Total Liabilities	-	169.33	124.47	149.68	193.59
Common Stock	-	99.02	99.02	99.02	74.26
Additional Paid-In Capital	-	2,583	2,558	2,482	1,409
Retained Earnings	-	-1,490	-1,290	-996.06	-694.54
Comprehensive Income & Other	-	-0.03	0.11	0.14	-0.07
Total Common Equity	1,101	1,192	1,367	1,585	788.76
Shareholders' Equity	1,101	1,192	1,367	1,585	788.76
Total Liabilities & Equity	-	1,362	1,492	1,735	982.35
Total Debt	106.67	9.05	12.85	35.76	3.91
Net Cash (Debt)	810.38	834.88	1,091	1,532	897.31
Net Cash Growth	-2.94%	-23.48%	-28.79%	70.74%	-21.16%
Net Cash Per Share	8.18	8.41	11.02	16.87	12.07
Filing Date Shares Outstanding	98.75	99.02	99.02	99.02	74.26
Total Common Shares Outstanding	99.02	99.02	99.02	99.02	74.26
Working Capital	-	738.59	1,040	1,473	763.91
Book Value Per Share	11.12	12.04	13.81	16.01	10.62
Tangible Book Value	1,070	1,162	1,336	1,554	788.76
Tangible Book Value Per Share	10.80	11.73	13.49	15.69	10.62
Machinery	-	17.15	15.49	14.85	11.16
Construction In Progress	-	314.5	169.54	73.76	3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.